Cargando…

Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies

Soft tissue sarcomas (STS) are heterogeneous rare malignancies comprising ~1% of all solid cancers in adults and including more than 70 histological and molecular subtypes with different pathological and clinical development characteristics. Over the last two decades, the increased knowledge of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caruso, Chiara, Garofalo, Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174622/ https://www.ncbi.nlm.nih.gov/pubmed/32351891 http://dx.doi.org/10.3389/fonc.2020.00509

Ejemplares similares

Targeted therapies for the treatment of soft tissue sarcoma
por: Fuchs, Jeffrey W., et al.
Publicado: (2023)

Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application
por: Agnoletto, Chiara, et al.
Publicado: (2023)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
por: Du, Xin-Hui, et al.
Publicado: (2020)

Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas
por: Harrer, Dennis Christoph, et al.
Publicado: (2021)

Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
por: Li, Long-Qing, et al.
Publicado: (2020)

Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk
por: Smolle, Maria Anna, et al.
Publicado: (2017)

Soft Tissue Sarcoma Cancer Stem Cells: An Overview
por: Genadry, Katia C., et al.
Publicado: (2018)

Local recurrence management of extremity soft tissue sarcoma
por: Serban, Bogdan, et al.
Publicado: (2023)

Spatial Outcomes of Soft Tissue Sarcoma in Southern West Virginia
por: Annie, Frank H, et al.
Publicado: (2020)

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?
por: Arthur, Amani, et al.
Publicado: (2022)

Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma
por: Jakob, Jens, et al.
Publicado: (2013)

Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
por: Li, Shenglong
Publicado: (2021)

Progresses in Fluorescence Imaging Guidance for Bone and Soft Tissue Sarcoma Surgery
por: Chen, Zhenyi, et al.
Publicado: (2022)

Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
por: Zhang, Qing, et al.
Publicado: (2023)

The efficacies and biomarker investigations of antiangiogenic agents and PD-1 inhibitors for metastatic soft tissue sarcoma: A multicenter retrospective study
por: Liu, Zhiyong, et al.
Publicado: (2023)

Soft-Tissue Sarcoma following Traumatic Injury: Case Report and Review of the Literature
por: Bar, Yael, et al.
Publicado: (2017)

Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
por: Lin, Lu-Lu, et al.
Publicado: (2021)

Outcomes of Wide Resection of Soft-Tissue Sarcoma of the Extremity: A Retrospective Analysis
por: Sheoran, Ajay, et al.
Publicado: (2022)

Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
por: Agnoletto, Chiara, et al.
Publicado: (2021)

Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma
por: Tu, Chao, et al.
Publicado: (2023)

Patterns of Practice Survey: Radiotherapy for Soft Tissue Sarcoma of the Extremities
por: Cho, Chan-Kyung J, et al.
Publicado: (2019)

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
por: Deel, Michael D., et al.
Publicado: (2015)

Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas
por: Tsoi, Kim M., et al.
Publicado: (2021)

Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma
por: Wang, Pingping, et al.
Publicado: (2021)

Impact of Limb Salvage on Prognosis of Patients Diagnosed With Extremity Bone and Soft Tissue Sarcomas
por: Yu, Kaixu, et al.
Publicado: (2022)

A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma
por: Li, Zhehong, et al.
Publicado: (2022)

Tumor cellularity beyond the visible in soft tissue sarcomas: Results of an ADC-based, single center, and preliminary radiomics study
por: Giraudo, Chiara, et al.
Publicado: (2022)

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2016)

Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
por: Pierantoni, Francesco, et al.
Publicado: (2019)

Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes
por: Huang, Wenjing, et al.
Publicado: (2021)

Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2023)

Similar additive effects of doxorubicin in combination with photon or proton irradiation in soft tissue sarcoma models
por: Bernardo, Teresa, et al.
Publicado: (2023)

Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M, et al.
Publicado: (2022)

Case Report: An Adolescent Soft Tissue Sarcoma With YWHAE-NUTM2B Fusion Is Effectively Treated With Combined Therapy of Epirubicin and Anlotinib
por: He, Jiajia, et al.
Publicado: (2022)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)
por: López-Pousa, A., et al.
Publicado: (2016)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
por: de Juan Ferré, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j0n8ajdjsf91rr3mvm59uvollu